These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19652523)

  • 1. Use of a sensitive chemiluminescence-based assay to evaluate the metabolic suppression activity of linezolid on methicillin-resistant Staphylococcus aureus showing reduced susceptibility to vancomycin.
    Komatsu M; Tajima Y; Ito T; Yamashiro Y; Hiramatsu K
    J Microbiol Biotechnol; 2009 Jul; 19(7):734-42. PubMed ID: 19652523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence-suppressing effects of linezolid on methicillin-resistant Staphylococcus aureus: possible contribution to early defervescence.
    Yoshizawa S; Tateda K; Saga T; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1744-8. PubMed ID: 22290944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients.
    Gonzalez N; Sevillano D; Alou L; Cafini F; Gimenez MJ; Gomez-Lus ML; Prieto J; Aguilar L
    J Antimicrob Chemother; 2013 Oct; 68(10):2291-5. PubMed ID: 23674766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
    Cesur S; Irmak H; Simşek H; Cöplü N; Kılıç H; Arslan U; Bayramoğlu G; Baysan BO; Gülay Z; Hoşoğlu S; Berktaş M; Gencer S; Demiröz AP; Esen B; Karabiber N; Aydın F; Yalçın AN
    Mikrobiyol Bul; 2012 Jul; 46(3):352-8. PubMed ID: 22951647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
    Shaw KJ; Poppe S; Schaadt R; Brown-Driver V; Finn J; Pillar CM; Shinabarger D; Zurenko G
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4442-7. PubMed ID: 18838596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
    Farrell DJ; Flamm RK; Sader HS; Jones RN
    Int J Antimicrob Agents; 2014 Apr; 43(4):323-7. PubMed ID: 24411474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test].
    Pelitli TS; Cesur S; Kınıklı S; Irmak H; Demiröz AP; Karakoç E
    Mikrobiyol Bul; 2011 Oct; 45(4):758-61. PubMed ID: 22090309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
    Efe S; Sinirtaş M; Ozakin C
    Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
    Kao TM; Wang JT; Weng CM; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Staphylococcus aureus and antibiotic resistance].
    Sancak B
    Mikrobiyol Bul; 2011 Jul; 45(3):565-76. PubMed ID: 21935792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
    Rio-Marques L; Hartke A; Bizzini A
    Microb Drug Resist; 2014 Dec; 20(6):539-43. PubMed ID: 25010140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA).
    Kaleem F; Usman J; Khalid A; Hassan A; Omair M
    J Pak Med Assoc; 2011 Apr; 61(4):356-9. PubMed ID: 21465972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey.
    Tekin A; Dal T; Deveci Ö; Tekin R; Özcan N; Atmaca S; Dayan S
    Braz J Microbiol; 2014; 45(3):829-33. PubMed ID: 25477914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The incidence and risk factors for heterogeneous vancomycin intermediate Staphylococcus aureus].
    Feng NN; Wang Q; Song YL; He LX; Zhou CM; Xie HM; Li HY
    Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):318-22. PubMed ID: 23925360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid and vancomycin decrease the therapeutic effect of methylene blue-photodynamic therapy in a mouse model of MRSA bacterial arthritis.
    Tanaka M; Mroz P; Dai T; Huang L; Morimoto Y; Kinoshita M; Yoshihara Y; Shinomiya N; Seki S; Nemoto K; Hamblin MR
    Photochem Photobiol; 2013; 89(3):679-82. PubMed ID: 23311407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of pacemaker-lead infection by linezolid-resistant methicillin-resistant Staphylococcus aureus in a hemodialysis patient].
    Kojiro M; Tsuchihashi Y; Ishida M; Furumoto A; Matsuda J; Yanagihara K; Morimoto K; Ariyoshi K
    Kansenshogaku Zasshi; 2012 Nov; 86(6):778-83. PubMed ID: 23367855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
    Locke JB; Hilgers M; Shaw KJ
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5265-74. PubMed ID: 19752277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.